Abstract
The transcription factor NF-κB controls the expression of hundreds of genes involved in the regulation of the immune/inflammatory response, development, and apoptosis. In resting cells, NF-κB proteins are sequestered in the cytoplasm through their tight association with IκB proteins. NF-κB activation relies on the signal-induced IκB phosphorylation and degradation, thereby allowing the nuclear translocation of NF-κB proteins. In the nucleus, several post-translational modifications of NF-κB and chromatin remodeling of target genes are mandatory for NF-κB DNA binding and full transcription. Since 1991, reactive oxygen species (ROS) have been implicated in NF-κB activation. ROS enhance the cytoplasmic signaling pathways leading to NF-κB nuclear translocation, but reduction/oxidation (redox) also controls several key steps in the nuclear phase of the NF-κB program, including chromatin remodeling, recruitment of co-activators, and DNA binding. Here we describe the redox regulation of NF-κB activity in the nucleus. Antioxid. Redox Signal. 11, 2209–2222.
Get full access to this article
View all access options for this article.
